Advocating for the recognition of underlying immunosuppression in critical illness
Open Access
- 1 July 2025
- journal article
- review article
- Published by Elsevier in eClinicalMedicine
- Vol. 85, 103300
Abstract
No abstract availableKeywords
Funding Information
- European Society of Intensive Care Medicine
This publication has 97 references indexed in Scilit:
- Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and International Society for Heart and Lung Transplantation: An executive summaryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2022
- Clinical perspectives on the age-related increase of immunosuppressive activityJournal of Molecular Medicine, 2022
- A flow cytometric assay for HLA‐DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trialsCytometry Part B: Clinical Cytometry, 2021
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA, 2020
- Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort studyIntensive Care Medicine, 2017
- Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shockIntensive Care Medicine, 2010
- Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shockIntensive Care Medicine, 2006
- Immunomodulation with interferon‐gamma and colony‐stimulating factors for refractory fungal infections in patients with leukemiaCancer, 2005
- Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patientsIntensive Care Medicine, 2002
- The Medical Course of Cancer Patients With Fever and NeutropeniaArchives of internal medicine (1960), 1988